Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hey Clay, after looking at the 8ks and PRs, I think you were right to be bullish on this one. However, in retrospect the Series A note was liquidated at a faster rate than expected, killing the run. Doing the math, I think the Series A note has been paid back in full now (or will be very shortly) which should allow the stock to turn into a sustainable upward trend. There are also quite a few volume catalysts for this one in the next couple weeks. Thanks and enjoy your videos.
Consensus Price Target: $3.44 (404.03% upside)
Get on board and make some $$$
Still worth $1.50-$2.50... People are going to feel stupid selling at these levels when a new product and company update are just around the bend.
Bounce to $1.50. There will almost certainly be a big PR in the next few days. $SGNL has a new product they haven't announced and they are expanding their MyPRS network every week. Who knows, at this low price they are a buy-out candidate
Bounce to $1.50. There will almost certainly be a big PR in the next few days. $SGNL has a new product they haven't announced and they are expanding their MyPRS network every week. Who knows, at this low price they are a buy-out candidate
Yup. With good investor relations this stock would be bouncing between $1.25 and $2.00. It has over $1.30 per share value in just cash reserves. But the company is not communicating positives to shareholders and there is no buying pressure... I think we could wake up to a good PR any day and see $1.50
Yes. Below $2 this is a gift. Grab these crazy discounted shares and wait. You don't usually get shares below cash value, below book value, and about a third of price target.
This stock is low resistance all the way to $1.30. Why do you care about $1.10? It already touched that level twice yesterday. $1.50 ish might still be a big resistance, but this thing is so low float that a little volume will break all resistances. Load up while it is so low and wait for a PR this company is the real deal.
Conference is afternoon and the presentation and glad handling the investors in 1 on 1s will take time. But just a few longs adding in here, with this tight float, will propel this company past the low volume resistances either today or tomorrow.
This is a strong company with huge upside. You can only push things down so far. I thought it was incredible how low this thing got. And it got that way with no negative press, all positives...
Waiting for the presentation. This board is way too quiet.
Agree completely. This needs to be a bull squeeze into news. Then we shoot past $2 maybe to $3 with enough volume. To make things even more enticing, SGNL is a good company for "real investors" as these longs eat up shares the float becomes even more volatile. I think we see a massive bounce in the near future. Hopefully most traders don't let go of their shares below $1.50.
The investor's conference will be illuminating. This is a strong company that is starting to capitalize on multiple partnerships. Huge upside, and yet it is trading below the cash value of the company because of an ugly biotech storm.
Looking pretty decent. Its finding its footing. Maybe more attacks in the future but I bet we see a nice week next week
Maybe a signal. I think this is some interesting manipulation. Trying to get cheap shares before the investor's conference.
Double down. Buy every share at this price. Seriously... You are buying below book value. Get the word out to everyone you know! This is probably the best value of any stock out there.
Double down. Buy every share at this price. Seriously... You are buying below book value. Get the word out to everyone you know! This is probably the best value of any stock out there.
A toe in the water...
You missed the plus sign =)
I haven't added more because I have 2 different investing accounts. One is my high risk and high reward account and the other is lower risk and lower reward. The lower risk, lower reward account has a lot more money in it but I also am more cautious with the investments. For me, Anavex is on the bubble of having a low enough risk profile for my second account (with the added benefit of high reward). The remaining data would push this over the edge for me. I will be purchasing 500k-1M shares when this happens. This is a $10+ stock with P3 success.
I do not read that slide the same way that you do. Preliminary in a tech/biotech company means non-formal (not published in a properly scrutinized and technical form). It does not mean a subset.
I am incredibly bullish on this stock and think that it is a game changer. I am just anxious for more data so that I can move a larger percentage of my portfolio in.
Where does it say the promised data was just the first 12 patients? I read it as the full 32 patient group. I am new to this board, not to Anavex.
Should have the Q3 data. I believe they said that the preliminary data on the rest of the Phase 2A patients should be out in Q3. I bet they have that in their pocket for the conference. If the remaining 20ish patients in the study have a similar positive reaction (10/12 in the first batch), that data should act as a major catalyst for Anavex.
This is a beautiful channel. I think it breaks green within the next few days and runs. This is a nice $1.25 - $1.27 battle, even with the market a little weak today.
The $0.52 bouncing we are seeing is the stock's resistance level. We need about another million shares traded to break through.
However, that has nothing to do with the long term potential of this thing. $TPIV is a gold mine!
Can't wait to see TPIV update! It is finally time for this stock to begin take-off!
Then you just have to wait for tomorrow =)
Now we just need the volume =) This is looking pretty!
I am guessing $1 in the short term with good news.
I think we finally get our inflection point with the 2 conferences and subsequent press.
I think we get an updated outlook, info on P2, and some more direction/strategy/vision statements.
I meant a short term play (swing trade), not shorting the stock. I am bullish short term and long term but I think there will be a lot of bumps in the road between here and $5.
Sell before Thurs = Moron
Seriously shorts. We have not one, but two big investor meetings on Wed and Thursday. This is a great long stock, but if you are a short, why would you even consider selling before Thurs?
Dilution solution, no constitution, raking in cash, no retribution
Where did everyone go? We have a nice little catalyst coming up and this board is too quiet. If the warrant dilution has slowed and we get some P2 news, this thing will have a nice pop~!
If we close above $.14, tomorrow will be off to the races. The PR will sink in and more people will be here.
This is a real weed stock. I wish all the investors wouldn't have blown their money on crap like FITX. This is a real company.
This might be a retirement of debt counts as income play. I have seen that before in start-ups. It will be interesting to analyze this ER and next quarter's as well.
Surna, how about a PR updating us on your Ops? Your PPS is ready =)
Volume is good today. A little troubling that the average price is 10% down from open. As long as we don't break through the floor, we should recover tomorrow. I am a little worried about what the ER will do to the momentum. Hopefully, they also produce a PR update on operations.
Nice volume but this ticker needs more exposure.
Why aren't more people paying attention to this stock? It is wound tight and poised to move big.